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tes or hypertension and racewed fewer revascularization procedures (22%) within 30 
days than man (35%, p<O.OOl). Unadjusted l-year swvival was not significantly different 
between men (8%) and women (9%). Advanced age (HRl.06 95%Cl(1.05-1.07)), histo- 
ries of myocardial infarction (MI) (1.7 (1.4-2.0)) 01 heart failure (1.7(1.3-2.1)), diabetes 
(1.3(1 .l-1.6)). hypercholesterolemia (1.3(1 .O-1.5)), ascending quartiles of troponin 
(1.4(1.0-1.9). 1.7(1.3-2.4), 2.2(1.6-3.0)), MI within 30 days (3.4(2.7-4.3)), elevated heart 
rate (1 .OZ(l .Ol-1.02)) and serum creatinine levels (1.4(1.3-1.6)) were associated with a 
higher l-year mortality in both genders, whereas, angioplasty within 30 days was associ- 
ated with lower risk of death (0.5(0.4-0.7)). ST-depresslon (1.3(1.0-l .7) p(interac- 
tion)<0.05) on admission and CRP>lOmg!L (1.3(1.0-l -8) p(interactlon)c0.05) were 
predictors of l-year death in men but not women. Men with Ml on admission were at 
pr* 8hrs 16hrs 24hrs 
Procedure successful (N) 54 
Tropon~n I - rise above 0.1 mgidL (N,(%)) l(2) 6(12) 5(10) 8(16) 
CWCK-MB rise (U/L) 0 0 0 0 
In-hospital events (N) 0 
ECG changes 2 
post procedure (N) 
Adverse events at 15 days (N) 2 
March 19,2003 
lower risk of death (0.6(0.4-0.8) p(interaction)=O.OOZ) than women or patients without Ml 
on admission. Conclusions: Although long-term prognosis is comparable between men Conclusion: Surprisingly, significant Troponin I wes were found in up to 16% of patients 
and women with NSTE-ACS. some predictors of death differ, which may have important 
that underwent a diagnostic angiogram for stable coronary artery disease, with no sigmf- 
icant lesions present. These findings may have an impact on conclusions drawn from 
implications for risk management and choice of treatment. previous lntetventional cardiology trials that suggested future events depended upon 
Troponin status following intervention. 
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1003-89 Is Enhanced External Counterpulsation Effective for 
Angina Relief in Diabetic Patients Who Are Not 
Candidates for Transcatheter Intervention? 
Georaiann C. Linnemeier, Elizabeth D. Kennard, Ozlem Soran, Shetyl F. Kelsey, 
University of Pittsburgh, Pittsburgh, PA 
Background: Percutaneous coronary Intervention in the diabetic patient is problematic. 
Enhanced external counterpulsation (EECP) is a noninvasive analogue of the intra-aortic 
balloon pump designed to increase myocardial perfusion pressure and decrease cardiac 
workload. EECP has been demonstrated to be safe and effectwe in treating angina; how- 
ever, the effectiveness of EECP for the treatment of angina in diabetic patients who are 
not considered candidates for transcatheter lntewention is unknown. 
Methods: We analyzed demographic and clinical outcome data from 616 diabetic 
patients (from 32 sites) diagnosed with Canadian Cardiovascular Society (CCS) class Ill 
or IV angina who were not revascularization candidates by referring physician’s assess- 
ment. EECP was given l-2 hours daily with 79% of patients completing a course of treat- 
ment (mean, 37 hours). Patients were followed for six months. 
Results: The mean age was 66 years. and 36% were female. Coronary artery disease 
was of long duration (mean, 11 years), frequently multwessel (81%), and most patients 
had prior percutaneous coronary intervention (74%) or coronary artery bypass surgery 
(72%). Congestive heart failure (44%), and previous myocardial infarction (73%) were 
reported often (mean left ventricular ejection fraction, 45%). Patients were highly symp- 
tomatic, reporting 11.5 episodes of angina/week, requirmg 10.2 sublingual nitroglycerin1 
week. Medical management was considered optimal. Upon completion of treatment, 
88% of patients reported a decrease of >= 1 CCS angina class wth 63% reporting class 
II, I, or no angina. There was a decrease of 8.7 angina1 episodes/week with a concomi- 
tant decrease of 13.2 nitroglycerin/week. At xx-month follow-up, angina reduction was 
maintained in 74% of patients with 74% repomng class II, I, of no angina. 
Conclusion: Despite steady improvement in transcatheter interventional techniques and 
outcomes, there is a growing population of patients who have exhausted the revascular- 
ization armamentarium. Novel treatments such as EECP can offer angina reduction with 
maintenance of benefit for select diabetic patients with advanced coronary artery dis- 
ease. 
Huerin Melina, B. Rolong, R. Henquin, R. Zilberberg, C. Gambarte, 0. Mendoza, M. 
Kriskovich, N. Vainstein, C. Zeballos, L. Guzman, lnstituto Cardiovascular de Buenos 
Aires, Buenos Aires, Argentina 
Increasing levels of homocysteine are strongly associated with the incidence of cardio- 
vascular disease. Recent report appears to indicate a clinical benefit in reducing 
homocysteine levels. Even though it is well established the effectiveness I” reducing 
homocysteine levels with wtamine B complex, the effect of diet is not well documented. 
The aim of the present study was to determine the role of folate-rich diet I” reducing 
homocysteine levels and to compare it effect with the vitamin reduction and with the reg- 
ular secondary prevention recommendations. Sixty patients with prior hlstory of CAD 
were randomly assigned to three different treatments strategies for a three months 
period. The vitamin group (Group V). received vitamin 69: 2.5 mg, B6: 25 mg, and 812: 
0.5 mg; the diet group recewed folate-rich diet (Group D) and a third group received the 
usual secondary preventIon recommendations, and sewed as control (Group C). Base- 
line and 3 months homocysteine levels were measured in all pts. Results: The compli- 
ance with the treatment strategy was 99% for group V and 80% for group D, (p: 0.001). 
Conclusions This prospective randomized study shows that f&ate-rich diet did not 
show any significant benefit in decreasmg homocysteine levels despite a relatively high 
compliance with the diet as compare with the usual secondary prevention recommenda- 
tlons. As expected, vitamin treatment successfully decrease homocysteine levels and 
was well tolerated. 
P from baseline to 3 month: ‘p:O.O2, **p:O.OOOl. 
Homocysteine 
urnoWL 
Baseline 
3 months 
Changes 
Grupo C 
(n:20) 
14+0.8 
12.4+0.7 
-1.7+0.8’ 
Grupo D 
(!l:20) 
14.2+0.8 
12.5+0.7 
-1.7+0.9 
Grupo V 
(n:20) 
16.4+0.98 
10.7+0.5 
-5.7+1.2” 
P Value 
NS 
NS 
0.007 
1003-114 Mildly Reduced Creatinine Clearance Is Associated With 
Coronary Artery Disease in Women: The NHLBI- 
Sponsored WISE Study 
Marian 8. Olson, Richard Holubkov, Linda Fried, Virgina Reeser, Sunil Mankad, Carl J. 
Pepine, Richard Kerensky, C. Noel Bairey Merz. Barry L. Sharaf, George Sopko, William 
J. Rogers, Steven E. Reis, University of Pittsburgh, Pittsburgh, PA 
1003-90 Cardiac Troponin I Rise Equally Occurs After 
Diagnostic Coronary Angiograms in Stable Patients 
Glenn Van Lanqenhove, Paul Vermeersch, Middelheim Hospital, Antwerp, Belgium 
Background: Troponin I has been suggested as an excellent and early marker of unsta- 
ble coronary artery disease. It has been lknked to future outcome of patients admitted to 
the hospital with unstable coronary syndromes, and in patients that received Interven- 
tional treatment. No literature exists on the occurrence of Troponin I rise following a diag- 
nostic angiogram 
Methods: Patients were only included if they did not have flow-llmiting lesions in their 
coronary artery tree. We prospectively measured Troponin I values before, and 8, 16 and 
24 hours after a diagnostic angiogram and at 14 days after the index procedure. Other 
cardiac enzymes were also assessed. 
Results: No events occurred during hospital stay nor the 14 day follow-up period. A sum- 
mary of the data available IS shown in the table. 
Background: Mild renal insufficiency is associated with an increased risk for cardiovascu- 
lar events in women with coronary artery disease (CAD). However, the relationship 
between mild renal insufficiency and atherosclerotic CAD has not been Investigated. 
Methods: 721 women with chest pal” underwent quantitative coronary angiography, risk 
factor and serum creatinine assessment in the Women’s lschemia Svndrome Evaluation 
(WISE) Study. Estimated creatinine clearance (mllmin) was calculated from serum creat- 
inine usino the Cockroft-Gault eouatlon. Of these. 248 i34%) had an estimated creatinme 
clearance of 50-80 mllmin, defined as mild renal insufficiency; 473 had an estimated 
clearance greater than 80 mllmin. normal renal function. Women with one or more >50% 
dtameter stenosis were classified as having significant CAD. CAD severity score was cal- 
culated using a modified Gensinl index. Interleukin-6 levels were measured in 508 
women. 
Results: As compared to women with normal creatmine clearance, those with mild renal 
Insufficiency were older (64 vs. 54 yrs., p<O.OOl) were more likely have higher systolic 
blood pressure (p=O.Ol), dyslipidemia (p=O.O5) and significant CAD (49% vs 30%, p 
=O.OOl). Modified Gensmi index scores were higher in these women (16 +/-I6 vs. 12 +I- 
12, p< 0.001). Women with mild renal insuffkxncy were 2.3 times more likely to have 
significant CAD (95% Cl 1.6.3.O)(p< 0.001) Mild renal insufficiency was associated with a 
1.6.fold (95% Cl=1 .O-2.6) wreased risk of CAD after adjustment for age. risk factors, 
interleukin 6 levels and use of hormone replacement therapy (pc 0.05). Similar finding 
were noted when using serum creatinine to define renal function. Serum creatinine levels 
of 1.2-1.9, defined as mild renal insufficiency, were associated with a 3.2 fold (95% 
CLl.4.7.2) increase of significant CAD independent of risk factors (pc 0.01) 
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POSTER SESSION Conclusion: In women with chest pain, mild renal insufficiency is an independent predic- 
tor of significant angiographic CAD. Impaired creatinine clearance may be a marker for 
unmeasured pro-atherogenic factors. 
1003-115 Randomized Comparison of Fenoldopam and N- 
Acetylcysteine to Saline in the Prevention of Radio- 
Contrast Induced Nephropathy 
Emmanuel Loutrianakis , Dominick St&a, Atif Hussain. Bruce Lewis, Lowell Steen, Mirek 
Sochanski, Fred Leya. Eric Grassman. Loyola University Medical Center, Maywood, IL 
Introduction: 5% of patients undergoing cardiac angiography experience radio-contrast 
induced nephropathy @IN). This risk triples in patients with renal insufficiency. The cur- 
rently accepted prophylaxis is intravenous hydration (IVF) with 0.45 NS. Emerging evi- 
dence suggest N-acetylcystetne (NAG) and fenoldopam (FEN) may also have a 
protective role. 
Methods: Patients with creatinine (Cr) > 1.5 mg/dL who had a cardiac anglogram were 
randomized to one of three treatment groups: 1) IVF with 0.45 NS at t cclkgmr pre end 
post procedure, 2) IVF as above plus 600-mg BID of NAC the day prior to and on the day 
of procedure, 3) IVF as above plus FEN at 0.1 mcglkglmin starting 30 min prior to and 
continuing for 4 hrs post procedure. Cr levels were drawn prior to the angiogram and at 
5-7 days after the procedure. The primary end-point of the study was an increase in Cr of 
0.5 mg/dL or a 25% increase from baseline. Results: 68 patients with a mean age 67+10 
(24% females, 76% males) and a mean Cr level of 1.92+0.34 mg/dL were randomized 
into the three treatment groups of IVF only, NAC, and FEN. Baseline characteristics for 
the groups were similar. A statistically greater number of patients in the NAC group had 
an increase in baseline Cr > 25% as compared to the other two treatment groups (see 
Table 1). Conclusion: In patients with renal insuffiaency, hydration with 0.45NS alone is 
as effective as FEN plus hydration in preventing RIN. The combination of NAC and IVF 
was the least effective regimen. 
Table 1: Patients with an increase in Cr a1 5-7 days. 
Hydration NAC Fenoldopam P- 
(~23) (n-24) (n=21) value 
Increase in Cr > 0.5 rng/ 3 6 1 0.155 
dL 
Increase in Cr > 25% 2 8 2 0.043 
1003-l 16 A Simple Clinical Score Is an Accurate Prognostic 
Indicator in a Community-Based Population 
Todd D. Miller, Veronique L. Roger, David 0. Hodge, Raymond J. Gibbons, Mayo Clinic, 
Rochester, MN 
Introduction: Clinical scoring systems have been developed for initial assessment of 
patients with coronary artery disease (CAD) but are not widely applied due to their com- 
plexity and lack of validation. The purpose of this study was to validate a simple clinical 
prognostic score, originally developed in a cohort of patients referred to our nuclear car- 
diology laboratory. in a “less-selected” community-based population. 
Methods: The score was deslgned specifically to use a limited number of clinical vari- 
ables and an integer system to simplify calculation and recall: 1 point each for male gen- 
der, typical angina, diabetes, insulin use, hlstory of myocardial infarction (MI), and 1 point 
for each decade of age beginning at age 40 (40-49=1. 50s59=2, etc) (range of score 0 to 
9). The score was applied to all residents of Olmsted County, MN undergoing an initial 
exercise test between January 1987 and December 1990 (w3566). 
Results: Clinical characteristics included: age 50+15, male 64%, typical angina 8%. dia- 
betes 5%, insulin use 3%, history of Ml 10%. Follow-up was 7.6~2.7 yrs. Annual event 
rates were strongly associated with the score: overall mortality x&525, pcO.001; cardiac 
death $=192, p<O.OOl; cardiac death or Ml~c274. p<O.OOl (see table). 
Conclusion: This simple prognostic score was highly accurate for risk-stratifying this 
community population, supporting a more wide-spread application of this score in 
patients with CAD. 
Score Patients Overall Mortality Cardiac Death Cardiac Death/Ml 
<4 3076 (86%) 0.6% 0.2% 1 .O% 
5 275 (8%) 2.4% 0.8% 2.0% 
>6 215 (6%) 6.2% 2.8% 4.2% 
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1004-92 Paclitaxel Reduces Neointimal Formation In Vitro and in 
a Porcine Model of Saphenous Vein Interposition 
Grafting 
Martin H. Chamberlain, Thomas W. Johnson, Yin Xiong Wu, Jason L. Johnson, Andrew 
C. Newby, Gianni D. Angelini, Karl R. Karsch, Matim Oberhoff, Bristol Heart Institute, 
University of Bristol, Bristol, United Kingdom 
Background: Following early thrombosis, IO-15% of coronary vein grafts fail over the 
next 5 years due to intimal thickening. Paclitaxel is a potent inhibitor of cell proliferation 
by inducing a sustained block of mitosis at the metaphasslanaphase boundary. The aim 
of this study was to investigate the effect of paclitaxel pre-treatment in a porcine model of 
Saphenous vein to carotid artery interposition grafting. Methods: In-vitro evaluation of 
the eHect of short-term paclitaxel exposure on neointimal proliferation involved saphen- 
ous vein pre-treatment, by suspension in Paclitaxel (10 FmollL) or vehicle control, for 1 
hour, prior to plating and 14 day culture. Samples were histologically analysed. Subse- 
quently, ten Large White pigs (25-33.5 kg) underwent bilateral saphenous vein to carotid 
artery interposition grafting. Each animal received a Paclitaxel treated and a vehicle con- 
trol graft. Animals were sacrificed at 29 days, vein graHs were harvested and pressure 
fixed prior to histologicallmorphometric analysis. Results: In-vitro Paclitaxel exposure 
resulted in a significant reduction in neointimal thickness, compared with vehicle control; 
77.80+1-48.8Qm vs 148.35+1-82.73Fm (p=O.OOS). Only patent grafts were included in 
the in-viva analysis (see table). 
Parameter Control (n=8) Treated (n=8) P value 
Lumlnal Area (mm? 32.08i15.45 25.26e15.53 0.017 
Neointimal Area (m&) 2.43tl.35 1.59t0.95 0.0004 
Medial Area (mm’) 6.83e2.57 6.18k5.84 0.25 
NeointimallMedial Ratio 0.37+0.18 0.299+0.16 0.029 
Conclusion: Our data demonstrates that Paclitaxel pre-treatment reduces neointima for- 
mation, in-vitro and in-viva Paclitaxel may be a highly attractive candidate for prevention 
of late vein graft failure. 
1004-94 Functional Myocardial Angiogenesis Resulting From 
Persistent Systolic Perfusion 
Marvin J. Slepian, Michael J. Mooney, Donald C. Harrison, Robed W. Emery, Randall K. 
Wolf, Katherine S. Tweden, University of Arizona, Tucson, AZ, Mtnnaapolis Heart 
Institute, Minneapolis, MN 
Background: The effects of systolic perfusion on distal coronary bed myocardium were 
studied by using a device that creates a permanent transmyocardial flow channel 
between the left ventricle and a coronary artery (Ventriculocoronary Artery Bypass 
(VCAB) procedure). Methods: The stent-like direct revascularization device (DRD), an 
L-shaped titanium tube with a meshed distal tip, was implanted between the leftventricu- 
lar cavity and the mid left anterior descending coronary artery (LAD) in 15 juvenile 
domestic pigs using a beating heart approach. The LAD was ligated proximal to the 
device. Patency was assessed via retrograde anglography at explant for surviving ani- 
mals at 12 weeks (n=12). Morphometry of blood vessels (150 fields total) was assessed 
in the subendocardium using PAX-It TM software. Hearts retrieved acutely from pigs were 
used as controls. 
Results: 3/15 animals died within 24 hours related to procedural complications. At 12 
weeks, patency was achieved in 1 l/12 pigs. Morphometric assessment of the target 
myocardium showed a significant increase in number of small (25-200 pm), medium 
(200-4OOpm) and large (>40@m) arterioles compared to the control in the subendocar- 
dial region (see graph). Conclusions: This study demonstrates persistent patency of a 
